NASD · Healthcare · Drug Manufacturers - Specialty & Generic · Canada
Cronos Group Inc is a small cap company (market value between $300 million and $2 billion) in the Drug Manufacturers - Specialty & Generic industry.
Cronos is a cannabinoid company that cultivates, processes and distributes cannabis products through licensed facilities in Canada and Israel. The company sells dried flower, edibles, vaporizers and other cannabis products under brands including Spinach, PEACE NATURALS, LIT and Lord Jones to adult-use and medical markets in Canada and international markets such as Germany, the UK, Australia and Switzerland.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Cronos Group Inc stock.
Overvalued: intrinsic value $2.64 per share, market price $3.30, margin of safety -24.8% (as of 2026-10-30).
A 1.3x revenue multiple, discounted for its losses, values the shares at $2.64; the price of $3.30 is 25% above that value.
Leak Score: 30/100 on 8 of 12 signals (On Watch).
All 84 Drug Manufacturers - Specialty & Generic stocks
14 more in this industry show a wider margin of safety.
CRON is overvalued (as of the 2026-10-30 close). A 1.3x revenue multiple, discounted for its losses, values the shares at $2.64; the price of $3.30 is 25% above that value.
$2.64 per share (as of the 2026-10-30 close), against a market price of $3.30. That is a margin of safety of -24.8%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
30 out of 100, which we rate "On Watch", on 8 of 12 value investing signals.